Published in Transpl Int on January 01, 1998
Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions. J Clin Invest (1999) 1.21
Differential modulation of surface and intracellular protein expression by T cells after stimulation in the presence of monensin or brefeldin A. Clin Diagn Lab Immunol (2002) 1.07
Influence of specimen age and use of different negative controls in determination of intracytoplasmic levels of cytokines after whole-blood culture assay. Clin Diagn Lab Immunol (2002) 0.82
Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet (1985) 10.67
Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J Clin Microbiol (1988) 4.05
Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J Med Virol (1988) 3.76
Conjugation of fluorescein isothiocyanate to antibodies. II. A reproducible method. Immunology (1970) 3.09
Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med (1989) 2.94
Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol (1995) 2.66
Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection. Clin Exp Immunol (1974) 2.57
Conjugation of fluorescein isothiocyanate to antibodies. I. Experiments on the conditions of conjugation. Immunology (1970) 2.56
Predictive capacity of pre-donation GFR and renal reserve capacity for donor renal function after living kidney donation. Am J Transplant (2006) 2.40
Increased cancer risk after liver transplantation: a population-based study. J Hepatol (2001) 2.25
Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum (1990) 2.24
Demonstration of IgM cytomegalovirus-antibodies as an aid to early diagnosis in adults. Clin Exp Immunol (1970) 2.24
Direct detection of cytomegalovirus in peripheral blood leukocytes--a review of the antigenemia assay and polymerase chain reaction. Transplantation (1992) 2.21
Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation--a report of 130 consecutive patients. Transplantation (1989) 2.20
Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med (2000) 2.19
Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis (1995) 2.16
Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet (1990) 2.12
Cytomegalovirus antigenemia. Rev Infect Dis (1990) 2.07
Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int (1990) 1.77
An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg (2001) 1.72
Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients. J Neurol Sci (1983) 1.69
The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. J Gen Virol (1992) 1.67
Detection of immunoglobulin M and G antibodies against cytomegalovirus early and late antigens by enzyme-linked immunosorbent assay. J Clin Microbiol (1984) 1.64
Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J Infect Dis (1993) 1.62
Choledochocholedochostomy, a relatively safe procedure in orthotopic liver transplantation. Surgery (1985) 1.61
Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation. J Infect Dis (1991) 1.59
Pneumatosis intestinalis and active cytomegaloviral infection after lung transplantation. Groningen Lung Transplant Group. Chest (1994) 1.56
Long-term outcome of lung transplantation is predicted by the number of HLA-DR mismatches. Transplantation (2001) 1.55
Analysis of survival and morbidity after pediatric liver transplantation with full-size and technical-variant grafts. Transplantation (1999) 1.52
Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors. Trop Med Int Health (2001) 1.51
Antibodies against cytomegalovirus-induced early antigens (CMV-EA) in immunosuppressed renal-allograft recipients. Clin Exp Immunol (1977) 1.49
Does lung transplantation prolong life? A comparison of survival with and without transplantation. J Heart Lung Transplant (1998) 1.47
Rapid decreases in donor-specific cytotoxic T lymphocyte precursor frequencies and graft outcome after liver and lung transplantation. Transplantation (2001) 1.42
Rapid detection of infectious cytomegalovirus in blood with the aid of monoclonal antibodies. J Med Virol (1987) 1.42
[Good results with liver resection for colorectal liver metastases]. Ned Tijdschr Geneeskd (1995) 1.40
Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies. Ann Rheum Dis (1982) 1.39
Cytomegalovirus antigenemia assay. J Clin Microbiol (1991) 1.39
Lung transplantation. Lancet (1998) 1.38
Tissue macrophages are infected by human cytomegalovirus in vivo. J Infect Dis (1996) 1.35
Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response. Clin Exp Immunol (1981) 1.34
Antibodies against membrane antigens of cytomegalovirus infected cells in sera of patients with a cytomegalovirus infection. Clin Exp Immunol (1972) 1.34
Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn Reson Med (1992) 1.33
Cytomegalovirus antigenemia: clinical correlations in transplant recipients and in persons with AIDS. J Clin Microbiol (1993) 1.33
Presence of human cytomegalovirus (HCMV) immediate early mRNA but not ppUL83 (lower matrix protein pp65) mRNA in polymorphonuclear and mononuclear leukocytes during active HCMV infection. J Gen Virol (1994) 1.30
Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens. J Clin Microbiol (1994) 1.29
Systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenon. Am J Med (1980) 1.28
Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. Cancer Res (1985) 1.28
Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study. Transplantation (2001) 1.25
Immune-complex glomerulopathy in patients treated with captopril. Lancet (1980) 1.23
The effect of lung transplantation on health-related quality of life: a longitudinal study. Chest (1998) 1.23
Acute cytomegalovirus infection and the host immune response. I. Development and maintenance of cytomegalovirus (CMV) induced in vitro lymphocyte reactivity and its relationship to the production of CMV antibodies. Clin Exp Immunol (1980) 1.22
B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis. Clin Exp Immunol (1983) 1.22
Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease. Am J Respir Crit Care Med (1998) 1.18
Quantitative measurement of cytomegalovirus-specific IgG and IgM antibodies in relation to cytomegalovirus antigenaemia and disease activity in kidney recipients with an active cytomegalovirus infection. Clin Exp Immunol (1990) 1.16
Primary renal graft thrombosis. Nephrol Dial Transplant (1996) 1.16
Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 plasma levels in neonatal sepsis. Pediatr Res (1993) 1.15
Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma. The Liver Transplant Group. Hepatology (1997) 1.14
Early detection of active cytomegalovirus (CMV) infection after heart and kidney transplantation by testing for immediate early antigenemia and influence of cellular immunity on the occurrence of CMV infection. J Clin Microbiol (1990) 1.14
Cytomegalovirus (CMV) antigenemia: rapid diagnosis and relationship with CMV-associated clinical syndromes in renal allograft recipients. Transplant Proc (1989) 1.13
Expression of anti-OV6 antibody and anti-N-CAM antibody along the biliary line of normal and diseased human livers. Hepatology (2001) 1.13
The cytomegalovirus antigenemia assay: a plea for standardization. Scand J Infect Dis Suppl (1995) 1.12
The DNA-binding protein pUL57 of human cytomegalovirus is a major target antigen for the immunoglobulin M antibody response during acute infection. J Clin Microbiol (1995) 1.12
The human immune response to alpha-haemocyanin of Helix pomatia. Acta Med Scand (1973) 1.11
Neuroendocrine differentiation antigen on human lung carcinoma and Kulchitski cells. Cancer Res (1985) 1.11
Direct visualisation and quantification of cellular cytotoxicity using two colour flourescence. J Immunol Methods (1992) 1.11
Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles. Magn Reson Med (1993) 1.11
Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am J Med (1991) 1.11
A standrard method for DNCB sensitization testing in patients with neoplasms. Cancer (1974) 1.11
Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors. Hepatology (1998) 1.11
Class-specific antibody titres (ELISA) against the primary immunogen Helix pomatia haemocyanin (HPH) in man. Clin Exp Immunol (1978) 1.10
Cytomegalovirus-directed lymphocyte reactivity in healthy adults tested by a CMV-induced lymphocyte transformation test. Clin Exp Immunol (1977) 1.10
Surgical treatment of giant haemangioma of the liver. Br J Surg (1997) 1.09
Platelet activation, fibrinolytic activity and circulating immune complexes in Raynaud's phenomenon. J Rheumatol (1983) 1.09
Choledochocholedochostomy is successful in orthotopic liver transplantation. Transplant Proc (1984) 1.09
[Liver transplantation: patients' experiences]. Ned Tijdschr Geneeskd (1989) 1.08
Surface antigens on cultured malignant melanoma cells as detected by a membrane immunofluorescence method with human sera. Lack of tumor-specific reactions on melanoma lines. Ann N Y Acad Sci (1975) 1.08
The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation. Clin Exp Immunol (1985) 1.07
Reticuloendothelial Fc receptor function in SLE patients. I. Primary HLA linked defect or acquired dysfunction secondary to disease activity? Clin Exp Immunol (1984) 1.07